• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Study Finds No Racial Disparity in COVID-19 Case Fatality Rates at Montefiore, When Controlling for Key Risk Factors

Article

Research by Montefiore and Albert Einstein College of Medicine found that Black and Hispanic patients had a higher occurrence of preexisting conditions and higher rates of hospitalization.

(BRONX, NY)—A study from Montefiore Health System and Albert Einstein College of Medicine published today in JAMA Network Open found that among 5902 ethnically diverse coronavirus disease 2019 (COVID-19)–positive patients admitted to Montefiore Medical Center, the outcomes for Black and Hispanic patients relative to their White counterparts were the same or better. 

The study shows that Black and Hispanic patients who were hospitalized with COVID-19 presented with more preexisting conditions, also known as comorbidities, as well as other risk factors. However, researchers found that Black and Hispanic patients had survival rates at least as good as their non-Hispanic White counterparts, when controlling for age, sex, socioeconomic status and comorbidities. Similar data trends have been shown in patients hospitalized in other major health systems in Louisiana and the Midwest.

“It is well-documented that communities of color have shouldered the heaviest burden of COVID-19 in the United States, and there have been many explanations offered for why that is the case,” said Andrew D. Racine, MD, PhD, system senior vice president and chief medical officer at Montefiore and professor of pediatrics at Einstein. “We discovered, somewhat surprisingly, that Black and Hispanic patients, when hospitalized, had similar or slightly better survival outcomes compared to White patients.”


Learn more.

Related Videos
Screenshot of an interview with Nadine Barrett, PhD
Neil Goldfarb, GPBCH
Dr Bonnie Qin
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
dr carol regueiro
dr carol regueiro
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.